Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1Recurrence 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Promyelocytic, Acute 1Leukemia, Prolymphocytic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Endometrial Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 7fludarabine phosphate 6Whole-Body Irradiation 6Cyclosporine 5Mycophenolic Acid 4Melphalan 3Filgrastim 3Etoposide 3Busulfan 3Blood Specimen Collection 3Antilymphocyte Serum 3Rituximab 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Carmustine 2zanubrutinib 1thymoglobulin 1plerixafor 1amuvatinib 1Transplantation 1Thiotepa 1Therapeutics 1Tacrolimus 1Radiotherapy 1Pentetic Acid 1Palliative Care 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Nutritional Support 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Waldenstrom Macroglobulinemia × Arsenic Trioxide × Clear all
NCT00005786 2013-02-01

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia

National Cancer Institute (NCI)

Phase NA Terminated
25 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡